Darwin Cell Biology was honored as one of the "2024 Top 10 Scientific and Technological Innovations in Neuropsychiatry" at the Health Industry Innovation Summit!

Article Summary.

On August 25, 2024, the much-anticipated Health Industry Innovation Summit 2024, a showcase of scientific and technological innovations in the field of neuropsychiatry, came to a successful conclusion. After layers of screening [...]

On August 25, 2024, the much-anticipated Health Industry Innovation Summit 2024, which showcases scientific and technological innovations in the field of neuropsychiatry, came to a successful conclusion. After layers of screening and fierce competition, Beijing Darwin Cell Biotechnology Co., Ltd.'s "Alitol - Innovative Drug Lighting up the Light of Nerve Repair" project stood out among many other projects due to its unique innovativeness, huge market potential and far-reaching social value, and was honored as "2024 Top 10 Scientific and Technological Innovations in Neuropsychiatric Field". Ltd. stood out from the crowd and was honored as one of the "2024 Top 10 Scientific and Technological Innovations in the Neuropsychiatric Field", which was then brilliantly presented to many investors in the Innovation Achievement Roadshow.

Since its establishment in 1988, the Beijing Neuroscience Society has been committed to promoting research and development in the field of neuroscience. The Society not only plays an important role in academic exchanges and scientific cooperation, but also makes remarkable contributions in promoting the display of scientific and technological innovations in the field of neuroscience.

The Health Industry Innovation Summit 2024 Neuropsychiatry Science and Technology Innovation Achievements Showcase, as the innovation venue of the 2024 Beijing Brain Science International Academic Conference, is guided by the Beijing Municipal Association of Science and Technology, co-sponsored by the Beijing Society of Neuroscience, the Beijing Association of Mobile Internet Health Services and the China Association for the Promotion of Private Science and Technology, and co-organized by the Department of Scientific and Technological Achievements Transformation of Capital Medical University and the Beijing Neuroprosthetics Industry Cooperation Consortium. Co-organized by the Beijing Municipal Association of Science and Technology, the event aims to promote the all-round integration of "government, industry, academia, research, application and finance" in the health industry, and to collect and strictly select the top innovative projects in the field of neuropsychiatry in the year of 2024 from all over the world. The authoritative jury led by academicians, domestic and foreign well-known experts and scholars, government leaders and senior investors will conduct a comprehensive evaluation of the projects based on a scientific and rigorous assessment system in terms of innovativeness, technological maturity, market potential and social benefits, and ultimately select the "2024 Top 10 Neuropsychiatry Science and Technology Innovations", which will represent the pinnacle of the industry. ".

The whole event was synchronously broadcasted live on Beijing Neuroscience Society, Science Association Channel, Arterial Network and Kouxiang Academic.

This event has set up a special "Innovation Achievement Roadshow Zone", which builds a bridge for high-quality projects selected as "TOP10" to connect directly with investment institutions, so that the projects can accurately convey their value and innovative essence, and lay a solid foundation for the subsequent investment and financing cooperation. This will lay a solid foundation for subsequent investment and financing cooperation. In addition, the selected projects will be given priority to participate in the "Private Science and Technology Development Contribution Award", and enjoy a series of customized services such as accelerated transformation of achievements, project cooperation and docking, investment and financing services, as well as policy consulting and intellectual property protection.

In the context of accelerated global population aging and lifestyle changes, neurological diseases have become one of the major causes of disability worldwide, and the second leading cause of death after cardiovascular diseases, accounting for more than 30% of the global population; they impose a heavy economic burden on families and society. In the face of this serious challenge, the limitations of traditional therapeutic means have become more and more prominent: the research and development of therapeutic drugs for neurological diseases are affected by a variety of factors, and effective therapeutic drugs and methods are extremely limited, with the approval rate of drug research and development being less than 50% of that of other diseases; the emergence of effective therapeutic drugs is urgently needed in the clinic.

The award of "2024 Top 10 Scientific and Technological Innovations in Neuropsychiatry" is not only a strong proof of Darwin Cell Biology's innovation ability and R&D strength, but also a great encouragement and encouragement for the company's future development. Darwin Cell Biology will take this opportunity to continue to uphold the spirit of scientific innovation, increase R & D investment, deepen the pace of technological accumulation and innovation breakthroughs, and is committed to contributing more innovative biomedical products with independent intellectual property rights to society, so as to make the life more quality.